There was also a trend towards increased CXCR3 and CCR7 expression; however they did not reach statistical significance (Fig.
← all excerpts
A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants.
1
—
—